Facial trauma is a frequent presentation to the emergency department following alcohol-related injuries. Brief alcohol intervention (BAI) is a form of a motivational interview which is implemented in the postinjury phase to educate patients on the detrimental effects of their alcohol drinking behavior and reduce their future consumption. This systematic review and meta-analysis aims to assess the impact of BAI on alcohol drinking behavior in the emergency department setting.
An extensive systematic literature review was implemented from 21 October 2020 to 23 November 2020. All clinical studies that reported the outcomes of brief alcohol intervention on alcohol consumption in patients who attended the emergency department with facial injuries were included in the systematic review. The data sources utilized include Google Scholar, PubMed, ISI, Scopus, EMBASE, SIGLE, Virtual Health Library, NYAM, ClinicalTruaks.Gov, Controlled Trials (mRCT), and ICTRP.
The current systematic review included 8 articles encompassing 941 patients. Of the included patients, 304 (32.3%) patients were subjected to BAI, while the remaining 637 (67.7%) were not subjected to BAI. BAI significantly decreased the amount of alcohol consumption 3 months after intervention (SMD -0.596; 95% CI -1.067, -0.126; P = .013). Patients who received BAI were 1.89 times more likely to reduce their alcohol consumption (OR 1.89; 95% CI 0.59, 6.11; P = .29).
BAI is an efficacious motivational tool for patients with facial trauma in the emergency setting. It can effectively reduce the amount and rate of alcohol consumption after facial trauma in the short-term. However, a higher level of evidence is required to reach long-term conclusions.

Effectiveness of Brief Alcohol Intervention in Reducing Alcohol Consumption Among Patients With Alcohol-Related Facial Trauma in the Emergency Department: A Systematic Review and Meta-Analysis.

Chronic gastritis (CG) is an inflammatory disease of the gastric mucosa. Shen-ling-bai-zhu san (SLBZS), a traditional Chinese medicine formula, is widely used for treating CG. Nevertheless, its effects are currently unclear.
To determine the clinical evidence and potential mechanisms of SLBZS for the treatment of CG.
We systematically searched 3 English (PubMed, Embase, Medline) and 4 Chinese databases (Cochrane Library Central Register of Controlled Trials, China National Knowledge Infrastructure database, Wanfang Data Knowledge Service Platform, and the VIP information resource integration service platform) without language or publication bias restriction. Qualified studies were selected according to pre-set inclusion and exclusion criteria. RevMan 5.3 software was used for meta-analysis and literature quality assessment, Stata 14.0 software was used for sensitivity analysis, GRADE profiler 3.6 was used to evaluate the quality of evidence. And then, network pharmacology analysis was applied to primary research the mechanisms of action of SLBZS on CG.
Fourteen studies were finally included, covering 1335 participants. Meta-analysis indicated that: (1) SLBZS was superior to conventional therapies [risk ratio (RR): 1.29, 95% confidence interval (CI): 1.21 to 1.37, 
SLBZS might be useful in treating CG, but long-term effects and specific clinical mechanisms of it maintain unclear. More samples and high-quality clinical experiments should be assessed and verified in the next step.

Chinese herbal formula shen-ling-bai-zhu-san to treat chronic gastritis: Clinical evidence and potential mechanisms.

Reply to Wang et al.'s commentary on Xue et al.: The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis.

A meta-analysis was conducted by systematically searching PubMed, Embase, and Cochrane Library databases till August 2020 for studies published in English. The reference lists of eligible studies were also searched. The motor symptoms (UPDRS-Part III), balance function (BBS and BESTest), functional mobility (TUG), anxiety (HADS and BAI), depression (HADS and BDI), and the quality of life (PDQ-39 and PDQ-8) were the primary evaluation indexes.
Ten studies including 359 participants were included in this meta-analysis. The pooled results showed significant difference between the yoga training group and the control group. Patients in the yoga training group had better functional outcomes in terms of motor status (MD = -5.64; 95% CI, -8.57 to -2.7), balance function (SMD = 0.42; 95% CI, 0.08 to 0.77), functional mobility (MD = -1.71; 95% CI, -2.58 to -0.84), anxiety scale scores (SMD = -0.72; 95% CI, -1.01 to -0.43), depression scale scores (SMD = -0.92; 95% CI, -1.22 to -0.62), and QoL (SMD = -0.54; 95% CI, -0.97 to -0.11).
Our pooled results showed the benefits of yoga in improving motor function, balance, functional mobility, reducing anxiety and depression, and increasing QoL in PD patients.

The Effects of Yoga on Patients with Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials.

We aimed to estimate the effect of mindfulness therapy on mental health.
Two researchers searched 12 databases to identify relevant trials that were published from 1 January 2018 to 1 May 2023. We performed a meta-analysis to determine the effect of mindfulness therapy on depression, which was measured by the Beck Depression Inventory (BDI), Patient Health Questionnaire-9 (PHQ-9), Quick Inventory of Depressive Symptomatology (QIDS), Hamilton Depression Rating Scale (HDRS), Patient-Reported Outcomes Measurement Information System (PROMIS), Hospital Anxiety and Depression Scale (HADS), and Depression Anxiety Stress Scales (DASS); anxiety, which was measured by the Beck Anxiety Inventory (BAI), PROMIS, and DASS, Generalized Anxiety Disorder-7 (GAD-7); stress, which was measured by the Perceived Stress Scale (PSS), DASS, and GAD-7; mindfulness, which was measured by the GAD-7, Five Facet Mindfulness Questionnaire (FFMQ), Mindful Attention Awareness Scale (MAAS), Short Form-12 Mental Component Score (SF-12 MCS) and Short Form-12 Physical Component Score (SF-12 PCS); and sleep quality, which was measured by the Pittsburgh Sleep Quality Index (PSQI). After screening studies based on the inclusion and exclusion criteria, 11 randomized controlled trials (RCTs) involving 1,824 participants were ultimately included.
All these studies demonstrated positive effects of mindfulness therapy on depression (SMD = -0.33, 95% CI: [-0.44, -0.22], 
In future studies, it is necessary to consider the investigation on whether the strategies of improving the mindfulness therapy in adherence and fidelity can work on the improvement of the outcomes in mental health.
https://www.crd.york.ac.uk/PROSPERO/, https://www.crd.york.ac.uk/PROSPERO/, identifier [CRD42023469301].

Papers